Charles Zhou

Stock Analyst at Guggenheim

(1.51)
# 3,472
Out of 5,044 analysts
11
Total ratings
62.5%
Success rate
-1.43%
Average return

Stocks Rated by Charles Zhou

Cogent Biosciences
Aug 25, 2025
Maintains: Buy
Price Target: $17$20
Current: $16.09
Upside: +24.30%
Futu Holdings
Mar 17, 2025
Maintains: Buy
Price Target: $130$136
Current: $187.74
Upside: -27.56%
Zymeworks
Mar 8, 2023
Reiterates: Buy
Price Target: $16
Current: $19.30
Upside: -17.10%
MacroGenics
May 5, 2022
Downgrades: Neutral
Price Target: n/a
Current: $1.85
Upside: -
PMV Pharmaceuticals
Aug 2, 2021
Initiates: Buy
Price Target: $56
Current: $1.47
Upside: +3,709.52%
Repare Therapeutics
Jun 28, 2021
Initiates: Buy
Price Target: $46
Current: $1.79
Upside: +2,469.83%
Qudian
Jan 22, 2020
Downgrades: Neutral
Price Target: n/a
Current: $4.73
Upside: -